Stocktoria

Protara Therapeutics, Inc. TARA

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2014-10-22 · LEI

Protara Therapeutics, Inc. statistics & valuation

Market cap$231.6M
P / B1.2×
Return on equity-29.2%
Return on capital-32.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-74.20% -86.30% -433.80% -17.10% -29.20% -64.60% -59.20% -26.70% -29.20% 2016201720182019202020212022202320242025
Shares outstanding
16.6M 17.7M 481091 2.6M 11.2M 11.2M 11.3M 11.4M 35.0M 53.6M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-65.50% -68.10% -88.10% -640.20% -16.70% -27.40% -58.20% -51.20% -24.60% -27.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$4.21 -$5.86 -$3.57 -$2.17 -$1.34 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-27.4%-24.6%-51.2%-58.2%-27.4%-16.7%-640.2%-88.1%-68.1%-65.5%
Return on equity-29.2%-26.7%-59.2%-64.6%-29.2%-17.1%368.0%-433.8%-86.3%-74.2%
Current ratio14.5815.7111.1715.0121.6658.130.237.554.718.42

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.